Mo C, Gasparetto C, Costa C, Cowan A, Mark T, Chai Y, Kashyap T, Katz J, Amatangelo M, Richardson P. P43 | SELINEXOR, MEZIGDOMIDE, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RELAPSED OR ARE INELIGIBLE FOR T-CELL–REDIRECTING THERAPY: STOMP PHASE 1 PRELIMINARY RESULTS. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14043.